We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Search Results

Showing 1-20 of 698 results
  1. Reirradiation for diffuse intrinsic pontine glioma: prognostic radiomic factors at progression

    Purpose

    Diffuse intrinsic pontine glioma (DIPG) is a lethal pediatric brain tumor. Radiation therapy (RT) is the standard treatment, with...

    Dominik Wawrzuta, Marzanna Chojnacka, ... Bożenna Dembowska-Bagińska in Strahlentherapie und Onkologie
    Article Open access 15 May 2024
  2. Prospective randomized clinical studies involving reirradiation: update of a systematic review

    Background

    Reirradiation is a potentially useful option for many patients with recurrent cancer, aiming at cure or symptom palliation, depending on...

    Carsten Nieder, Jonas Willmann, Nicolaus H. Andratschke in Strahlentherapie und Onkologie
    Article Open access 27 July 2023
  3. Post-mastectomy reirradiation for ipsilateral T3N0M0 breast tumor relapse: a population-based study

    Introduction

    Post-mastectomy radiotherapy is commonly recommended for T3N0M0 breast cancer, particularly in the presence of adverse prognostic...

    Pierre Loap, Youlia Kirova in Strahlentherapie und Onkologie
    Article 02 January 2024
  4. The evolving role of reirradiation in the management of recurrent brain tumors

    Despite aggressive management consisting of surgery, radiation therapy (RT), and systemic therapy given alone or in combination, a significant...

    Raffaella De Pietro, Lucy Zaccaro, ... Giuseppe Minniti in Journal of Neuro-Oncology
    Article Open access 25 August 2023
  5. Linac-based stereotactic salvage reirradiation for intraprostatic prostate cancer recurrence: toxicity and outcomes

    Background

    The rates of local failure after curative radiotherapy for prostate cancer (PC) remain high despite more accurate locoregional treatments...

    Salvatore Cozzi, Sebastiano Finocchi Ghersi, ... Cinzia Iotti in Strahlentherapie und Onkologie
    Article Open access 02 February 2023
  6. Reirradiation on spine metastases: an Italian survey on behalf of palliative care and reirradiation study groups of Italian association of radiotherapy and clinical oncology (AIRO)

    Aim

    This survey derived from the collaboration between the Palliative Care and Reirradiation Study Groups of the Italian Association of Radiotherapy...

    Rossella Di Franco, Donato Pezzulla, ... Ernesto Maranzano in Clinical and Translational Oncology
    Article 26 September 2022
  7. Reirradiation with radiosurgery or stereotactic fractionated radiotherapy in association with regorafenib in recurrent glioblastoma

    Purpose

    No standard treatment has yet been established for recurrent glioblastoma (GBM). In this context, the aim of the current study was to evaluate...

    Fabiana Gregucci, Fiorella Cristina Di Guglielmo, ... Alba Fiorentino in Strahlentherapie und Onkologie
    Article 21 November 2023
  8. Early effectiveness and toxicity outcomes of reirradiation after breast conserving surgery for recurrent or new primary breast cancer

    Purpose

    Breast reirradiation (reRT) after breast conserving surgery (BCS) has emerged as a viable alternative to mastectomy for women presenting with...

    Camille Hardy-Abeloos, Julie Xiao, ... Naamit Gerber in Breast Cancer Research and Treatment
    Article 05 January 2023
  9. Reirradiation versus systemic therapy versus combination therapy for recurrent high-grade glioma: a systematic review and meta-analysis of survival and toxicity

    Purpose

    This review compares reirradiation (reRT), systemic therapy and combination therapy (reRT & systemic therapy) with regards to overall survival...

    Ravi Marwah, Daniel Xing, ... Sweet Ping Ng in Journal of Neuro-Oncology
    Article Open access 21 September 2023
  10. Lomustine with or without reirradiation for first progression of glioblastoma, LEGATO, EORTC-2227-BTG: study protocol for a randomized phase III study

    Background

    Chemotherapy with lomustine is widely considered as standard treatment option for progressive glioblastoma. The value of adding...

    Matthias Preusser, Tomáš Kazda, ... Giuseppe Minniti in Trials
    Article Open access 07 June 2024
  11. Comparison of carbon ion and photon reirradiation for recurrent glioblastoma

    Purpose

    Purpose of this study was to investigate overall survival in recurrent glioblastoma treated with either carbon ion reirradiation or photon...

    F. S. Lautenschlaeger, R. Dumke, ... F. Eberle in Strahlentherapie und Onkologie
    Article Open access 14 September 2021
  12. Reirradiation of Recurrent and Second Primary Cancers of the Head and Neck: a Review of the Contemporary Evidence

    Recurrent and second primary head and neck cancers represent a clinical challenge due to frequently unresectable and/or locally advanced disease....

    Paul J. Kreinbrink, Luke M. Lewis, ... Vinita Takiar in Current Treatment Options in Oncology
    Article 28 February 2022
  13. Reirradiation of head and neck squamous cell carcinomas: a pragmatic approach, part II: radiation technique and fractionations

    Introduction

    Reirradiation (reRT) of local recurrent/second primary tumors of the head and neck represents a potential curative treatment for patients...

    Daniela Alterio, Mattia Zaffaroni, ... Melissa Scricciolo in La radiologia medica
    Article 06 July 2023
  14. Reirradiation of head and neck squamous cell carcinomas: a pragmatic approach—part I: prognostic factors and indications to treatment

    Introduction

    Reirradiation (reRT) of locally recurrent/second primary tumors of the head and neck region is a potentially curative treatment for...

    Daniela Alterio, Mattia Zaffaroni, ... Melissa Scricciolo in La radiologia medica
    Article 20 September 2023
  15. Predictors of toxicity after curative reirradiation with intensity modulated radiotherapy or proton therapy for recurrent head and neck carcinoma: new dose constraints for pharyngeal constrictors muscles and oral cavity

    Background

    Our study aims to identify predictive factors of moderate to severe (grade ≥ 2) late toxicity after reirradiation (reRT) of recurrent head...

    Arnaud Beddok, Xavier Maynadier, ... Valentin Calugaru in Strahlentherapie und Onkologie
    Article 31 May 2023
  16. Optimizing reirradiation for relapsed medulloblastoma: identifying the ideal patient and tumor profiles

    Background

    First-line therapies for medulloblastoma(MBL) are obtaining higher survival-rates while decreasing late-effects, but treatment at relapse...

    Maura Massimino, Sabina Vennarini, ... Francesco Barretta in Journal of Neuro-Oncology
    Article 16 June 2023
  17. How ten-years of reirradiation for paediatric high-grade glioma may shed light on first line treatment

    Purpose

    Recurrence incidence for paediatric/adolescent high-grade glioma (HGG) exceeds 80%. Reirradiation (reRT) palliates symptoms and delays further...

    Maura Massimino, Sabina Vennarini, ... Veronica Biassoni in Journal of Neuro-Oncology
    Article 09 July 2022
  18. Stereotactic Body Radiation Therapy in Recurrent Head and Neck Cancer: Where Do We Stand?

    This review explores the difficulties encountered in the management of head and neck cancer (HNC), with special attention to the challenges presented...

    Jyotiman Nath, Moniprom Neog, ... Apurba Kumar Kalita in Indian Journal of Otolaryngology and Head & Neck Surgery
    Article 05 January 2024
  19. Pilot Evaluation of Perioperative High Dose Rate Brachytherapy in Head Neck Cancers

    Perioperative high dose rate brachytherapy involves insertion of brachytherapy catheter over the tumor bed during surgical removal of disease...

    Amit Bahl, Naresh K. Panda, ... Jaimanti Bakshi in Indian Journal of Otolaryngology and Head & Neck Surgery
    Article 08 January 2024
  20. Reirradiation salvage radiotherapy for recurrent prostate cancer after primary low-dose brachytherapy

    Purpose

    Local recurrence of prostate cancer after low-dose rate brachytherapy is a clinical problem with limited salvage treatment options. This...

    Óscar Muñoz Muñoz, Elías Gomis Sellés, ... Patricia Cabrera Roldán in Clinical and Translational Oncology
    Article 06 September 2023
Did you find what you were looking for? Share feedback.